Product Code: ETC13202544 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Blood Plasma Derivative Market was valued at USD 12 Billion in 2024 and is expected to reach USD 16 Billion by 2031, growing at a compound annual growth rate of 4.30% during the forecast period (2025-2031).
The Global Blood Plasma Derivative Market is a rapidly growing sector driven by increasing demand for plasma-derived therapies in various medical applications. Plasma derivatives are essential for treating a wide range of conditions, including immunodeficiency disorders, hemophilia, and autoimmune diseases. The market is also fueled by advancements in biotechnology and healthcare infrastructure, enabling efficient production and distribution of plasma-derived products worldwide. Key players in the market are investing in research and development to introduce innovative therapies and expand their product portfolios. However, regulatory challenges and ethical concerns surrounding plasma collection and utilization may hinder market growth. Overall, the Global Blood Plasma Derivative Market is expected to continue its upward trajectory due to the rising prevalence of chronic diseases and increasing healthcare expenditure globally.
The Global Blood Plasma Derivative Market is experiencing a surge in demand due to the growing prevalence of chronic diseases, rising geriatric population, and increasing surgical procedures worldwide. Key trends in the market include the development of innovative plasma-derived products, technological advancements in manufacturing processes, and a focus on personalized medicine. Opportunities in the market lie in the expansion of therapeutic applications for blood plasma derivatives, especially in rare diseases and immune disorders, as well as the potential for market growth in emerging economies. Moreover, strategic collaborations, partnerships, and acquisitions among key players are expected to drive market growth and foster innovation in the blood plasma derivative sector.
The Global Blood Plasma Derivative Market faces various challenges, including stringent regulatory requirements and quality control standards, limited availability of plasma donors, volatility in pricing, and increasing competition from alternative therapies. Regulatory barriers, such as stringent testing and validation requirements, can lead to delays in product approvals and market entry. The limited availability of plasma donors poses a significant challenge in meeting the growing demand for plasma-derived products. Pricing volatility can impact profit margins and hinder market growth. Additionally, the emergence of alternative therapies and advancements in biotechnology pose a threat to the market`s traditional dominance. Overcoming these challenges will require innovation in manufacturing processes, strategic partnerships, and a focus on improving efficiency in plasma collection and processing to ensure a sustainable future for the Blood Plasma Derivative Market.
The Global Blood Plasma Derivative Market is primarily driven by the increasing prevalence of chronic and rare diseases requiring plasma-derived therapies, such as hemophilia, immune deficiencies, and neurological disorders. Additionally, the rising demand for plasma-derived products in emerging economies, advancements in plasma fractionation techniques, and growing investment in research and development activities are also contributing to market growth. Furthermore, the expanding geriatric population, which is more susceptible to age-related health issues necessitating plasma-derived treatments, is fueling the market. Moreover, the increasing awareness about plasma donation and its importance in healthcare systems is driving the availability of raw materials for plasma fractionation, further boosting market expansion.
Government policies related to the Global Blood Plasma Derivative Market typically focus on ensuring the safety, quality, and availability of blood plasma products. Regulatory bodies such as the FDA in the United States and the EMA in Europe set guidelines for the collection, processing, and distribution of blood plasma derivatives to prevent contamination and ensure efficacy. These policies also address issues of donor eligibility, testing requirements, and traceability of products to maintain a reliable supply chain. Additionally, governments may implement pricing regulations and reimbursement policies to make these life-saving products accessible to patients in need while promoting fair competition among manufacturers in the market. Overall, government policies play a crucial role in promoting public health and safety within the blood plasma derivative industry.
The Global Blood Plasma Derivative Market is expected to witness steady growth in the coming years, driven by factors such as increasing prevalence of chronic diseases, growing aging population, and advancements in healthcare infrastructure. The rise in demand for plasma-derived therapies, including immunoglobulins, clotting factors, and albumin, for the treatment of various diseases such as immune deficiencies, hemophilia, and liver cirrhosis, is projected to fuel market expansion. Additionally, the ongoing research and development activities focused on developing innovative plasma-derived products are likely to create new growth opportunities. However, stringent regulatory requirements and the potential risk of infectious diseases transmission through blood plasma derivatives may pose challenges to market growth. Overall, the Global Blood Plasma Derivative Market is anticipated to exhibit a positive trajectory, driven by increasing demand for plasma-derived therapies and technological advancements in the healthcare sector.
In the Global Blood Plasma Derivative Market, Asia is witnessing significant growth due to the increasing prevalence of chronic diseases and a rising geriatric population. North America dominates the market with advanced healthcare infrastructure and a high demand for plasma-derived products. Europe follows closely with a strong focus on research and development in the field of biotechnology. The Middle East and Africa region are experiencing steady growth driven by improving healthcare facilities and government initiatives to enhance the healthcare sector. Latin America shows potential for growth due to increasing awareness about plasma-derived therapies and improving healthcare infrastructure. Overall, the global blood plasma derivative market is expanding across all regions, driven by factors such as increasing demand for plasma-derived products, technological advancements, and rising investment in healthcare infrastructure.
Global Blood Plasma Derivative Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Blood Plasma Derivative Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Blood Plasma Derivative Market Revenues & Volume, 2021 & 2031F |
3.3 Global Blood Plasma Derivative Market - Industry Life Cycle |
3.4 Global Blood Plasma Derivative Market - Porter's Five Forces |
3.5 Global Blood Plasma Derivative Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Blood Plasma Derivative Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Blood Plasma Derivative Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Global Blood Plasma Derivative Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Blood Plasma Derivative Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Blood Plasma Derivative Market Trends |
6 Global Blood Plasma Derivative Market, 2021 - 2031 |
6.1 Global Blood Plasma Derivative Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Blood Plasma Derivative Market, Revenues & Volume, By Albumin, 2021 - 2031 |
6.1.3 Global Blood Plasma Derivative Market, Revenues & Volume, By Factor VII, 2021 - 2031 |
6.1.4 Global Blood Plasma Derivative Market, Revenues & Volume, By Factor IX concentrate, 2021 - 2031 |
6.1.5 Global Blood Plasma Derivative Market, Revenues & Volume, By Anti-coagulation factor, 2021 - 2031 |
6.1.6 Global Blood Plasma Derivative Market, Revenues & Volume, By Rh immunoglobulin, 2021 - 2031 |
6.1.7 Global Blood Plasma Derivative Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Blood Plasma Derivative Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Blood Plasma Derivative Market, Revenues & Volume, By Immunodeficiency Diseases, 2021 - 2031 |
6.2.3 Global Blood Plasma Derivative Market, Revenues & Volume, By Bleeding Disorders, 2021 - 2031 |
6.2.4 Global Blood Plasma Derivative Market, Revenues & Volume, By Liver Conditions, 2021 - 2031 |
6.2.5 Global Blood Plasma Derivative Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Blood Plasma Derivative Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Blood Plasma Derivative Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Blood Plasma Derivative Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.3.4 Global Blood Plasma Derivative Market, Revenues & Volume, By Transfusion Centers, 2021 - 2031 |
7 North America Blood Plasma Derivative Market, Overview & Analysis |
7.1 North America Blood Plasma Derivative Market Revenues & Volume, 2021 - 2031 |
7.2 North America Blood Plasma Derivative Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Blood Plasma Derivative Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Blood Plasma Derivative Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Blood Plasma Derivative Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Blood Plasma Derivative Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Blood Plasma Derivative Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Blood Plasma Derivative Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Blood Plasma Derivative Market, Overview & Analysis |
8.1 Latin America (LATAM) Blood Plasma Derivative Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Blood Plasma Derivative Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Blood Plasma Derivative Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Blood Plasma Derivative Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Blood Plasma Derivative Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Blood Plasma Derivative Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Blood Plasma Derivative Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Blood Plasma Derivative Market, Revenues & Volume, By Application, 2021 - 2031 |
8.5 Latin America (LATAM) Blood Plasma Derivative Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Blood Plasma Derivative Market, Overview & Analysis |
9.1 Asia Blood Plasma Derivative Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Blood Plasma Derivative Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Blood Plasma Derivative Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Blood Plasma Derivative Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Blood Plasma Derivative Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Blood Plasma Derivative Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Blood Plasma Derivative Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Blood Plasma Derivative Market, Revenues & Volume, By Application, 2021 - 2031 |
9.5 Asia Blood Plasma Derivative Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Blood Plasma Derivative Market, Overview & Analysis |
10.1 Africa Blood Plasma Derivative Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Blood Plasma Derivative Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Blood Plasma Derivative Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Blood Plasma Derivative Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Blood Plasma Derivative Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Blood Plasma Derivative Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Blood Plasma Derivative Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Blood Plasma Derivative Market, Revenues & Volume, By Application, 2021 - 2031 |
10.5 Africa Blood Plasma Derivative Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Blood Plasma Derivative Market, Overview & Analysis |
11.1 Europe Blood Plasma Derivative Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Blood Plasma Derivative Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Blood Plasma Derivative Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Blood Plasma Derivative Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Blood Plasma Derivative Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Blood Plasma Derivative Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Blood Plasma Derivative Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Blood Plasma Derivative Market, Revenues & Volume, By Application, 2021 - 2031 |
11.5 Europe Blood Plasma Derivative Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Blood Plasma Derivative Market, Overview & Analysis |
12.1 Middle East Blood Plasma Derivative Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Blood Plasma Derivative Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Blood Plasma Derivative Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Blood Plasma Derivative Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Blood Plasma Derivative Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Blood Plasma Derivative Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Blood Plasma Derivative Market, Revenues & Volume, By Application, 2021 - 2031 |
12.5 Middle East Blood Plasma Derivative Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Blood Plasma Derivative Market Key Performance Indicators |
14 Global Blood Plasma Derivative Market - Export/Import By Countries Assessment |
15 Global Blood Plasma Derivative Market - Opportunity Assessment |
15.1 Global Blood Plasma Derivative Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Blood Plasma Derivative Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Blood Plasma Derivative Market Opportunity Assessment, By Application, 2021 & 2031F |
15.4 Global Blood Plasma Derivative Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Blood Plasma Derivative Market - Competitive Landscape |
16.1 Global Blood Plasma Derivative Market Revenue Share, By Companies, 2024 |
16.2 Global Blood Plasma Derivative Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |